We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
From Apr 2019 to Apr 2024
By Stephen Nakrosis
Elanco Animal Health Inc. (ELAN) said it received a second request for information from the U.S. Federal Trade Commission regarding its planned acquisition of Bayer AG's animal health business.
In August, the two companies announced a deal that will see Elanco acquire the unit in a cash-and-stock deal valued at $7.6 billion. At the time, the companies said the transaction was expected to close by the middle of next year.
Elanco said Monday, "The request was anticipated as part of the regulatory process under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the review continues to progress as expected."
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
December 09, 2019 18:30 ET (23:30 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Bayer Chart |
1 Month Bayer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
